Page last updated: 2024-08-21

arsenic trioxide and Kidney Diseases

arsenic trioxide has been researched along with Kidney Diseases in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (28.57)24.3611
2020's5 (71.43)2.80

Authors

AuthorsStudies
Abdel-Wahab, BA; El-Shoura, EAM; Shafiuddin Habeeb, M; Zafaar, D1
Abdel-Rahman, N; El-Gayar, AM; El-Karef, A; Maghmomeh, AO1
Cheng, J; Chu, L; Guan, S; Han, X; Jin, W; Li, Z; Song, Q; Sun, S; Xue, Y; Zhang, J1
Chu, L; Chu, X; Han, X; Liang, Y; Liu, P; Shi, J; Xue, Y; Zhang, J; Zheng, B1
Hu, L; Huang, R; Jiang, X; Lan, J; Tang, Z; Wan, F; Wu, S; Yu, W; Zhang, X; Zhong, G1
Li, Y; Liu, L; Ma, D; Xue, J; Yu, M; Zhang, W; Zhang, Z1
D'Andrea, DM; Darwish, M; Porter, JM; Remick, SC; Sweeney, CJ; Takimoto, C; Tracewell, WG; Wood, L1

Other Studies

7 other study(ies) available for arsenic trioxide and Kidney Diseases

ArticleYear
Febuxostat alleviates Arsenic Trioxide-Induced renal injury in Rats: Insights on the crosstalk between NLRP3/TLR4, Sirt-1/NF-κB/TGF-β signaling Pathways, and miR-23b-3p, miR-181a-5b expression.
    Biochemical pharmacology, 2023, Volume: 216

    Topics: Animals; Arsenic Trioxide; Febuxostat; Kidney; Kidney Diseases; MicroRNAs; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Signal Transduction; Toll-Like Receptor 4; Transforming Growth Factor beta

2023
Arsenic trioxide and curcumin attenuate cisplatin-induced renal fibrosis in rats through targeting Hedgehog signaling.
    Naunyn-Schmiedeberg's archives of pharmacology, 2020, Volume: 393, Issue:3

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Cisplatin; Curcumin; Drug Delivery Systems; Drug Therapy, Combination; Fibrosis; Hedgehog Proteins; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Signal Transduction

2020
Tannic acid ameliorates arsenic trioxide-induced nephrotoxicity, contribution of NF-κB and Nrf2 pathways.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 126

    Topics: Animals; Antioxidants; Apoptosis; Arsenic Trioxide; Disease Models, Animal; Inflammation; Interleukins; Kidney; Kidney Diseases; Male; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Rats; Tannins

2020
Crocetin attenuates the oxidative stress, inflammation and apoptosisin arsenic trioxide-induced nephrotoxic rats: Implication of PI3K/AKT pathway.
    International immunopharmacology, 2020, Volume: 88

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Arsenic Trioxide; Carotenoids; Kidney; Kidney Diseases; Male; Oxidative Stress; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Vitamin A

2020
Protective effects of curcumin on ATO-induced nephrotoxicity in ducks in relation to suppressed autophagy, apoptosis and dyslipidemia by regulating oxidative stress.
    Ecotoxicology and environmental safety, 2021, Volume: 219

    Topics: Animals; Antioxidants; Apoptosis; Arsenic Trioxide; Autophagy; Curcumin; Ducks; Dyslipidemias; Kidney; Kidney Diseases; Oxidative Stress; Protective Agents; TOR Serine-Threonine Kinases

2021
Resveratrol protects against arsenic trioxide-induced nephrotoxicity by facilitating arsenic metabolism and decreasing oxidative stress.
    Archives of toxicology, 2013, Volume: 87, Issue:6

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Arsenic Trioxide; Arsenicals; Blood Urea Nitrogen; Catalase; Cats; Creatinine; Cytoprotection; Deoxyguanosine; Glutathione; Glutathione Peroxidase; Injections, Intravenous; Kidney; Kidney Diseases; Malondialdehyde; Oxidative Stress; Oxides; Resveratrol; Stilbenes; Superoxide Dismutase

2013
A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment.
    Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Arsenic Trioxide; Arsenicals; Biotransformation; Female; Humans; Karnofsky Performance Status; Kidney Diseases; Male; Methylation; Middle Aged; Neoplasms; Oxides

2010